Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Galectin Therapeutics, Inc. (GALT) Names Jack Callicutt As Chief Financial Officer 0 comments
    Jun 21, 2013 5:38 PM | about stocks: GALT

    Galectin Therapeutics, a leading developer of therapeutics that specifically target galectin proteins in order to treat fibrosis and types of cancer, announced today that Jack W. Callicutt has been recruited to the position of Chief Financial Officer; effective as of July 1, 2013.

    Callicutt will oversee Galectin's financial activities, of which include interaction with capital markets, financial reporting, accounting, risk management, public company governance, as well as public and investor relations. As an active member of the senior management team, Callicutt will play a key position in shaping overall corporate strategy and advising on advance key product assets in the clinic. He will also help insure that financial resources are realized in order to achieve its vision for its pipeline of clinical development assets, a necessity in order to create shareholder value.

    "Jack's demonstrated leadership and deal-making capabilities coupled with his financial management experience and industry knowledge makes him an ideal fit with the needs of the company and further consolidates our leadership group in the Atlanta office. I am looking forward to working closely with Jack and am excited to add an individual of Jack's caliber to our management team," stated Dr. Peter G. Traber, Chief Executive Officer and Chief Medical Officer of Galectin Therapeutics Inc. "I also wish to sincerely thank Mr. Thomas McGauley for his years of service to the company, including the last 14 months as acting CFO, and for agreeing to work closely with Jack to assure an orderly transition."

    With over 22 years of public and private company experience, Callicutt holds more than a decade of audit, tax, and SEC registrant experience with a major accounting firm. Most recently he held the position of CFO for REACH Health, Inc., a telemedicine firm, where he successfully implemented a $4 MM private placement. He also previously held positions that include the title of CFO of Vystar Corporation, where he oversaw all areas of financial reporting, accounting, treasury, risk management and administration, as well as secured over $4.5 MM in financing. Furthermore Callicutt acted as CFO for private companies, including IVOX, Tikvah Therapeutics, and Coratus Genetics, a publicly traded biopharmaceutical company. Noting his broad background of experiences spanning a variety of technology intensive industries followed by over a decade-long of holding senior level positions at Deloitte, Callicutt will be a great contribution to the advancement of Galectin.

    Callicutt graduated cum laude with a BBA degree in Accounting and Computer science from Delta State University and is a Certified Public Account. Additionally, Callicutt is an active member in community affairs such as the Atlanta Community Food Bank and Habitat for Humanity. He currently resides with his family in Alpharetta, Georgia.

    To learn more, visit www.galectintherapeutics.com

    Please see disclaimer on the MissionIR website
    http://www.missionir.com/disclaimer.html

    Stocks: GALT
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.